134 related articles for article (PubMed ID: 35324007)
1. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
[TBL] [Abstract][Full Text] [Related]
4. National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey.
McAuley A; Gousias P; Hasan T; Rashid L; Richardson C; Reid G; Templeton K; McGuire J; Wise H; McVicar L; Jenks S; Gunn R; Dickson E; Stock SJ; Stockton A; Waugh C; Wood R; McMenamin J; Robertson C; Goldberg DJ; Palmateer NE
Public Health; 2021 Oct; 199():17-19. PubMed ID: 34517289
[TBL] [Abstract][Full Text] [Related]
5. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
6. Response: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
Sharma KA
Int J Gynaecol Obstet; 2022 Aug; 158(2):495-496. PubMed ID: 35698851
[No Abstract] [Full Text] [Related]
7. Letter to the Editor: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
Sookaromdee P; Wiwanitkit V
Int J Gynaecol Obstet; 2022 Aug; 158(2):494. PubMed ID: 35698856
[No Abstract] [Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.
Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506
[TBL] [Abstract][Full Text] [Related]
9. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
[TBL] [Abstract][Full Text] [Related]
10. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
11. High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya.
Awandu SS; Ochieng Ochieng A; Onyango B; Magwanga RO; Were P; Atieno Ochung' A; Okumu F; Oloo MA; Katieno JS; Lidechi S; Ogutu F; Awuor D; Kirungu JN; Orata F; Achieng J; Oure B; Nyunja R; Muok EMO; Munga S; Estambale B
PLoS One; 2022; 17(12):e0272751. PubMed ID: 36548358
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women.
González R; Nhampossa T; Figueroa-Romero A; Mendes A; Mazuze M; García-Otero L; Sevene E; Piqueras M; Egri N; Bedini JL; Saúte F; Menendez C
J Acquir Immune Defic Syndr; 2023 Feb; 92(2):115-121. PubMed ID: 36287578
[TBL] [Abstract][Full Text] [Related]
13. Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study.
Li J; Ge M; Dai S; Song Q; Liu W; Wang Y; Xu W; Ma L
Front Immunol; 2022; 13():1030238. PubMed ID: 36420275
[TBL] [Abstract][Full Text] [Related]
14. Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
Zhang X; Han X; Chen B; Fu X; Gong Y; Yang W; Chen Q
PLoS One; 2024; 19(3):e0289255. PubMed ID: 38452000
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
Essomba RG; Bayibeki AN; Lissom A; Ateba PT; Seni N; Fouda CAN; Mbitock SBD; Ebonda ND; Afana SD; Akame S; Tembu AA; Ngamaleu MR; Bimai BCB; Kabo O; Nguwoh PS; Ngounouh CT; Meka MCJ; Kengne M; Likeng JN; Kimessoukie EO; Nkoum BA; Assoumou MCO; Fokam J; Yap Boum II; Ambomo MS; Chadou MJP
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13222. PubMed ID: 37964992
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.
Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV
Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773
[TBL] [Abstract][Full Text] [Related]
18. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.
Almehmadi M; Salih MM; Shafie A; Alsharif A; Alsiwiehr N; El-Askary A; Alzahrani K; Al-Hazmi A; Aljuaid A; Abdulazziz O; Almalki AA; Allahyani M; Eed E; Alharbi AM; Halawi M; Allam HH; Abutawil H; Alosimi E; Gharib AF
Clin Lab; 2022 Nov; 68(11):. PubMed ID: 36378000
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Anti-SARS-CoV-2 IgG and IgM Antibodies among Government Employees in Iran.
Mohammad Hossein ZJ; Mehran D
Arch Razi Inst; 2023 Oct; 78(5):1413-1420. PubMed ID: 38590673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
